1 |
Ischenko I,Seeliger H,Kleespies A, et al. Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications. Langenbecks Arch Surg, 2010, 395(1): 1-10.
|
2 |
Er O. Cancer Stem Cells in Solid Tumors. Oncology, 2009, 32(10): 605-609.
|
3 |
Li H,Li X,Lam KS, et al. Adeno-associated virus-mediated pancreatic and duodenal homeobox gene-1 expression enhanced differentiation of hepatic oval stem cells to insulin-producing cells in diabetic rats. J Biomed Sci, 2008, 15(4): 487-497.
|
4 |
Mancino MG,Carpino G,Onori P, et al. Hepatic "stem" cells: state of the art. Ital J Anat mbryol, 2007, 112(2): 93-109.
|
5 |
Roskams T. Different types of liver progenitor cells and their niches. Hepatology, 2006, 45(1): 1-4.
|
6 |
Shafritz DA,Oertel M,Menthena A, et al. Liver stem cells and prospects for liver constitution by transplanted cells. Hepatology, 2006, 43(2): S89-S98.
|
7 |
Yovchev MI,Zhang J,Neufeld DS, et al. Thymus cell antigen-1-expressing cells in the oval cell compartment. Hepatology, 2009, 50(2): 601-611.
|
8 |
Virginie P,Nicolas F. Origin of small hepatocyte-like progenitor in retrorsine-treated rats. J Hepatol, 2008, 48(2): 368-369.
|
9 |
Best DH,Coleman WB. Treatment with 2-AAF blocks the small hepatocyte-like progenitor cell response in retrorsine-exposed rats. J Hepatol, 2007, 46(6): 1055-1063.
|
10 |
Johnnidis JB,Camargo FD. Isolation and functional characterization of side population stem cells. Methods Mol Biol, 2008, 430: 183-193.
|
11 |
Chiba T,Kita K,Zheng YW, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology, 2006, 44(1): 240-251.
|
12 |
Fan J,Li R,Zhang R, et al. Effect of Bcl-2 and Bax on survival of side population cells from hepatocellular carcinoma cells. World J Gastroenterol, 2007, 13(45): 6053-6059.
|
13 |
Tavaluc RT,Hart LS,Dicker DT, et al. Effects of low confluency, serum starvation and hypoxia on the side population of cancer cell lines. Cell Cycle, 2007, 6(20): 2554-2562.
|
14 |
Dittmar T,Nagler C,Schwitalla S, et al. Recurrence cancer stem cells-made by cell fusion? Med Hypotheses, 2009, 73(4): 542-547.
|
15 |
Bindya J,Motomi O,Namiko Y, et al. Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis. Blood, 2010, 115(8): 1610-1620.
|
16 |
Ikegami T. Transforming growth factor-beta signaling and liver cancer stem cell. Hepatol Res, 2009, 39(9): 847-849.
|
17 |
Tang Y,Kitisin K,Jogunoori W, et al. Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proc Natl Acad Sci USA, 2008, 105(7): 2445-2450.
|
18 |
You H,Ding W,Rountree CB. Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta. Hepatology, 2010. [Epub ahead of print]
|
19 |
Shi GM,Xu Y,Fan J, et al. Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials. J Cancer Res Clin Oncol, 2008, 134(11): 1155-1163.
|
20 |
Zhang A,London R,Schulz FM, et al. Human liver progenitor cell lines are readily established from non-tumorous tissue adjacent to hepatocellular carcinoma. Hepatology, 2009, 50(4): 903A..
|
21 |
Yang X,Fan J,Yang XR, et al. High expression levels of putative hepatic stem/progenitor cells biomarkers related to tumor angiogenesis and poor prognosis of hepatocellular carcinoma. J Am Coll Surg, 2009, 209(3):S89.
|
22 |
Nie D. Cancer stem cell and niche. Front Biosci, 2010, 2: 184-193.
|
23 |
Kuhn NZ,Tuan RS. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol, 2010, 222(2): 268-277.
|
24 |
Liu JM,Mao BY,Hong S, et al. The postoperative brain tumour stem cell (BTSC) niche and cancer recurrence. Adv Ther, 2008, 25(5): 389-398.
|
25 |
Soderdahl G,Barkholt L,Hentschke P, et al. Liver transplantation followed by adjuvant nonmyeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humans. Transplantation, 2003, 75(7): 1061-1066.
|
26 |
Xu X,Xing B,Hu M, et al. Recurrent hepatocellular carcinoma cells with stem cell-like properties: possible targets for immunotherapy. Cytotherapy, 2009, ahead of print.
|
27 |
Chiba T,Miyagi S,Saraya A, et al. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma. Cancer Res, 2008, 68(19): 7742-7749.
|